JP Stock MarketDetailed Quotes

4594 BrightPath Biotherapeutics

Watchlist
  • 51
  • -3-5.56%
20min DelayMarket Closed Nov 29 15:30 JST
4.35BMarket Cap-2800P/E (Static)

BrightPath Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:JPY
2024/FY
Stock NameRevenueRatio
Drug development business72K100.00%
Region Currency:JPY
2024/FY
Stock NameRevenueRatio
Japan72K100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg

No Data